These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34771496)

  • 1. MicroRNAs in Molecular Classification and Pathogenesis of Breast Tumors.
    Richard V; Davey MG; Annuk H; Miller N; Dwyer RM; Lowery A; Kerin MJ
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes.
    Kurozumi S; Yamaguchi Y; Kurosumi M; Ohira M; Matsumoto H; Horiguchi J
    J Hum Genet; 2017 Jan; 62(1):15-24. PubMed ID: 27439682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
    Sherafatian M
    Gene; 2018 Nov; 677():111-118. PubMed ID: 30055304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications.
    Asleh K; Riaz N; Nielsen TO
    J Exp Clin Cancer Res; 2022 Sep; 41(1):265. PubMed ID: 36050786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance.
    Zhao S; Ma D; Xiao Y; Li XM; Ma JL; Zhang H; Xu XL; Lv H; Jiang WH; Yang WT; Jiang YZ; Zhang QY; Shao ZM
    Oncologist; 2020 Oct; 25(10):e1481-e1491. PubMed ID: 32406563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive review.
    Szymiczek A; Lone A; Akbari MR
    Clin Genet; 2021 May; 99(5):613-637. PubMed ID: 33340095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
    Kao KJ; Chang KM; Hsu HC; Huang AT
    BMC Cancer; 2011 Apr; 11():143. PubMed ID: 21501481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype.
    Blenkiron C; Goldstein LD; Thorne NP; Spiteri I; Chin SF; Dunning MJ; Barbosa-Morais NL; Teschendorff AE; Green AR; Ellis IO; Tavaré S; Caldas C; Miska EA
    Genome Biol; 2007; 8(10):R214. PubMed ID: 17922911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refinement of breast cancer molecular classification by miRNA expression profiles.
    Søkilde R; Persson H; Ehinger A; Pirona AC; Fernö M; Hegardt C; Larsson C; Loman N; Malmberg M; Rydén L; Saal L; Borg Å; Vallon-Christerson J; Rovira C
    BMC Genomics; 2019 Jun; 20(1):503. PubMed ID: 31208318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer intrinsic subtype classification, clinical use and future trends.
    Dai X; Li T; Bai Z; Yang Y; Liu X; Zhan J; Shi B
    Am J Cancer Res; 2015; 5(10):2929-43. PubMed ID: 26693050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell State Transitions and Phenotypic Heterogeneity in Luminal Breast Cancer Implicating MicroRNAs as Potential Regulators.
    Richard V; Nair MG; Jaikumar VS; Jones S; Prabhu JS; Kerin MJ
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the hidden heterogeneities of breast cancer based on functional miRNA cluster.
    Li L; Liu C; Wang F; Miao W; Zhang J; Kang Z; Chen Y; Peng L
    PLoS One; 2014; 9(1):e87601. PubMed ID: 24498150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
    Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
    Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtyping of breast cancer improves identification of both high and low risk patients.
    Rossing M; Østrup O; Majewski WW; Kinalis S; Jensen MB; Knoop A; Kroman N; Talman ML; Hansen TVO; Ejlertsen B; Nielsen FC
    Acta Oncol; 2018 Jan; 57(1):58-66. PubMed ID: 29164972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
    Li D; Xia H; Li ZY; Hua L; Li L
    Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the intrinsic differences among breast tumor subtypes defined using immunohistochemistry markers based on the decision tree.
    Li Y; Tang XQ; Bai Z; Dai X
    Sci Rep; 2016 Oct; 6():35773. PubMed ID: 27786176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
    Qattan A
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins.
    Myhre S; Lingjærde OC; Hennessy BT; Aure MR; Carey MS; Alsner J; Tramm T; Overgaard J; Mills GB; Børresen-Dale AL; Sørlie T
    Mol Oncol; 2013 Jun; 7(3):704-18. PubMed ID: 23562353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.